Prospective Study of Patients With Thrombocytopenia Following HSCT

NCT02487563 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Thrombocytopenia
Hematologic Diseases

Interventions

DRUG: Decitabine
DRUG: rhTPO
OTHER: Conventional Treatment

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]